Humalog and Chromium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Chromium (chromium). Common drug interactions include blood glucose increased among females and blood glucose increased among males.
The phase IV clinical study analyzes what interactions people have when they take Humalog and Chromium. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.
What is Humalog?
Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.
What is Chromium?
Chromium has active ingredients of chromium. It is often used in metabolism. eHealthMe is studying from 2,557 Chromium users. Check the latest studies of Chromium.
eHealtheMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
78 people who take Humalog and Chromium together, and have interactions are studied.

What are the common drug interactions of Humalog and Chromium, by gender? *:
female:
- Blood glucose increased
- Weight increased
- Cataract (clouding of the lens inside the eye)
- Gait disturbance
- Malaise (a feeling of general discomfort or uneasiness)
- Cellulitis (infection under the skin)
- Full blood count decreased
- Hypoaesthesia (reduced sense of touch or sensation)
- Insomnia (sleeplessness)
- Pruritus (severe itching of the skin)
male:
- Blood glucose increased
- Diarrhoea
- Cardiac failure congestive
- Chest pain
- Contusion (a type of hematoma of tissue in which capillaries)
- Cough
- Depression
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Fall
- Nausea (feeling of having an urge to vomit)
What are the common drug interactions of Humalog and Chromium, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Blood glucose decreased
- Blood glucose increased
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Agitation (state of anxiety or nervous excitement)
- Asthma
- Blood glucose fluctuation
- Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
- Insomnia (sleeplessness)
- Malaise (a feeling of general discomfort or uneasiness)
- Stress
50-59:
- Renal failure (kidney dysfunction)
- Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
- Chronic kidney disease
- Compression fracture (fracture due to pressure caused by injury)
- Headache (pain in head)
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
- Pancreatitis (inflammation of pancreas)
- Papillary thyroid cancer
- Pituitary tumour benign
- Plasma cell myeloma (cancer that begins in plasma cells)
60+:
- Blood glucose increased
- Drug ineffective
- Fall
- Abdominal discomfort
- Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
- Bladder disorder
- Blood zinc decreased
- Cystitis (inflammation of the wall of the bladder)
- Femur fracture
- Micturition urgency (urgency to pass the urine)
What are the existing conditions these people have? *
- Type 2 Diabetes: 13 people, 16.67%
- High Blood Cholesterol: 10 people, 12.82%
- Pain: 9 people, 11.54%
- Blood Pressure Abnormal: 9 people, 11.54%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 11.54%
- Type 1 Diabetes: 7 people, 8.97%
- Gastric Disorder (disease of stomach): 6 people, 7.69%
- Neuropathy Peripheral (surface nerve damage): 6 people, 7.69%
- Multiple Myeloma (cancer of the plasma cells): 6 people, 7.69%
- Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 6 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Humalog and Chromium?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Humalog and Chromium:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Humalog:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Chromium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Humalog and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Chromium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on insulin lispro recombinant and chromium (the active ingredients of Humalog and Chromium, respectively), and Humalog and Chromium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zenapax cause Leukopenia? - 5 seconds ago
- Hydrocortisone and Flovent drug interactions for men aged 60+ - 10 seconds ago
- Temaz and Nplate drug interactions for men aged 60+ - 11 seconds ago
- Wellbutrin and Unipolar Depression for Men aged 30-39 - 19 seconds ago
- Wellbutrin and Major Depressive Disorder for Men aged 30-39 - 19 seconds ago
- Wellbutrin and Depression - Major for Men aged 30-39 - 20 seconds ago
- Wellbutrin and Major Depression for Men aged 30-39 - 20 seconds ago
- Drug interactions of Benadryl and Lenvatinib - 21 seconds ago
- Drug interactions of Heparin Sodium and Lopressor - 24 seconds ago
- Could Miralax cause Oropharyngeal Pain? - 28 seconds ago